iifl-logo

Balaxi Pharmaceuticals Ltd Cash Flow Statement

58.37
(-3.15%)
Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Balaxi Pharma FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

19.69

20.59

9.26

-0.76

Depreciation

-0.25

-0.08

0

0

Tax paid

-5.03

-5.46

-2.76

0

Working capital

5.53

-0.38

25.39

-0.78

Other operating items

Operating

19.94

14.65

31.87

-1.55

Capital expenditure

1.67

0.59

0.18

0.01

Free cash flow

21.61

15.24

32.05

-1.54

Equity raised

66.49

36.22

17.08

-1.44

Investing

0.07

19.44

0.1

0

Financing

5.44

3.51

0

0

Dividends paid

0

0

0

0

Net in cash

93.61

74.42

49.24

-2.98

Balaxi Pharma : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.